Tranexamic Acid Injection, Solution
Product Images NDC 25021-418

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 25021-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tra1f 0000 01)

Chemical structure of Tranexamic Acid showing a six-membered cyclic ring with an amino group and a carboxylic acid functional group.*

FDA Label Image

Package Label – Principal Display Panel – Bag Label (Tra1f 0000 02)

Label for Tranexamic Acid 10 mg/mL injection in 0.7% Sodium Chloride, 100 mL single-dose container, intravenous infusion. Contains 1,000 mg per 100 mL solution. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL. Label states sterile, preservative-free, and instructions for immediate use after removing overwrap.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.